Harnessing the power of synthetic biology to combat COVID-19

Webinar

Learn how Dr. Dan Gibson and team approached completing the world’s first on-demand synthesis of the SARS-CoV-2 genome — the causal agent of COVID-19 — using a commercially available, automated DNA assembly and cloning instrument — the BioXp® system.

The webinar from April 30, 2020, explores the hierarchical assembly of the full-length synthetic SARS-CoV-2 genome and its potential applications.